BioSpace News Archive

Microbiome restoration biological drug product to be tested for safety and overall survival impact in patients with acute Graft-versus-Host-Disease

Ipsen today announced that cabozantinib (Cabometyx®), irinotecan liposome injection (Onivyde®), lanreotide (Somatuline®) and the combination of lanreotide and telotristat (Xermelo®) are the subject of 12 presentations at the 2018 European Society for Medical Oncology (ESMO) annual congress. The meeting takes place in Munich, Germany, October 19-23, 2018.

On October 10, 2018, ThermoLife International, LLC filed suit in Arizona Federal District Court against Vital Pharmaceuticals, Inc. (“VPX”).

A series of local events and career progression resources to support women living and working with a chronic disease

Alliqua BioMedical, Inc. and Adynxx, Inc. today announced that they have entered into a definitive merger agreement under which the stockholders of Adynxx would become the majority owners of Alliqua’s outstanding common stock on a fully-diluted basis.

The Delta Dental Community Care Foundation recently awarded the HACC Foundation a $50,000 grant to upgrade dental equipment in its dental clinic at the Harrisburg Campus of HACC, Central Pennsylvania’s Community College.

Rockwell Medical (NASDAQ: RMTI) (the “Company” or “Rockwell Medical”) today provided an update on the status of the Company’s development of an intravenous (“IV”) formulation of the Company’s proprietary drug Triferic®, which is the only FDA-approved therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease.

Varian (NYSE: VAR) today announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based, mobile service designed to capture cancer patient-reported outcomes (PROs).

Cerus Corporation (Nasdaq: CERS) announced today its schedule of key events and presentations at the 2018 AABB Annual Meeting which is taking place in Boston on October 13 through October 16.

PathogenDx, Inc., the innovative provider of DNA-based pathogen testing technology for the cannabis industry, announced today the release of the first quantitative microarray-based test for cannabis, PDx-Quant™,